Skip to main content
Health protection

Research and statistics

Skip to results
1,062 results that are All research and statistics, sorted by Updated (newest)
  • Weekly data from UK laboratories on the number of cases of notifiable bacteria and viruses.

  • A national public health bulletin for England and Wales from the UK Health Security Agency (UKHSA).

  • Qualitative assessment of the risk that Usutu virus presents to the UK population.

  • This annual report covers surgical site infection (SSI) data collected by NHS hospitals and independent sector NHS treatment centres.

  • Report on the uptake of flu and COVID-19 vaccination in frontline healthcare workers (HCWs) since the start of the national programme in England.

  • Technical briefing documents on the investigation into influenza A(H1N2)v in England.

  • Technical report on inequalities in emergency hospital admission rates for influenza and COVID-19 in England, from September 2022 to February 2023.

  • Public health analysis of progress towards meeting the aims of England’s HIV Action Plan 2022 to 2025.

  • The third publication of the One Health Report brings together antibiotic resistance and consumption data from humans, animals, food, and the environment.

  • Total laboratory-confirmed cases of measles in England and Wales.

  • Voluntary surveillance of streptococcal bacteraemia in England.

  • This rapid review aims to identify and summarise evidence on the global epidemiology of sporotrichosis.

  • Data on trends in antimicrobial resistance and decreased susceptibility in gonococcal infection in England and Wales are provided by GRASP.

  • Counts and rates of MRSA, MSSA, E. coli, P. aeruginosa, Klebsiella spp. bacteraemia and C. difficile infection reported by independent sector healthcare organisations, with accompanying commentary.

  • Findings from the 2023 attitudinal survey of young people and parental attitudes to immunisations.

  • The Joint Committee on Vaccination and Immunisation (JCVI) statement setting out its recommendation on a universal varicella (chickenpox) vaccination programme.

  • JCVI statement setting out advice on the use of the 4CMenB vaccine for the prevention of gonorrhoea in those who are at increased risk of infection.

  • Statement setting out the advice from JCVI on the use of the MVA-BN vaccination for the prevention of mpox.

  • Reports presenting 30-day all-cause mortality following infection with healthcare-associated infections (HCAI).

  • Interim public health and implementation evaluation of the first 12 months of the opt-out bloodborne virus testing in emergency departments programme in England.